PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for February 10, 2009 Subscribe to this News Feed    
 

14th Annual Wharton Health Care Business Conference to Feature CEOs from WebMD, McKesson, Humana and Given Imaging

The 2009 Wharton Health Care Business Conference, an MBA-student organized event, will be held February 19-20 in Philadelphia. The dynamic two-day event will feature distinguished speakers and panelists from Healthcare Services, Investment, Pharma, Biotech, and Medical Device sectors.

Philadelphia, PA (PRWEB) February 10, 2009 -- The 2009 Wharton Health Care Business Conference, an MBA-student organized event, will be held February 19-20 at the Park Hyatt Hotel at The Bellevue in Philadelphia, PA. Distinguished speakers and panelists from across the health care industry include:

News Image

 
  • Wayne Gattinella - President, CEO, Director, WebMD
  • John Hammergren - Chairman, President, CEO, McKesson
  • Michael McCallister - President, CEO, Humana
  • Israel Makov - Chairman, Given Imaging, Former CEO, Teva Pharmaceuticals
  • Kent Thiry - Chairman, CEO, DaVita
  • Ronald Paulus - Executive Vice President, CTO, CIO, Geisinger Health System

Discussion Panel Sessions offered include:
 
  • The Blurring Line Between Pharma and Biotech - Featuring panelists from Wyeth, Pfizer, Amgen, Bank of America Merrill Lynch Securities, Orbimed, and Booz & Co.
  • Overcoming Hurdles: Financing Growth In A Capital Constrained World - Featuring panelists from JP Morgan, Aisling Capital, Johnson & Johnson Development Corporation, Cain Brothers & Co., and Deloitte Consulting
  • Policy: Will Reform Become Reality? - Featuring panelists from Independence Blue Cross, Putnam Associates, American Medical Association, New America Foundation, and McKinsey
  • The Global Market's Impact On Medical Devices - Featuring panelists from Synthes, Abbott Vascular, Johnson & Johnson Medical Brazil, Angel Medical Systems, and Boston Consulting Group
  • New Paradigms for Venture Financing: The Future Of Early Stage Investment - Featuring panelists from NEA, Novartis Options Fund, Polaris Ventures, Forward Ventures, CHL Medical Partners, and Pulmatrix

The Focus On Innovation Session will bring together promising start-ups and venture capitalists in a dynamic forum. This year's advisory board include investors from Johnson & Johnson Development Corporation, SR One, Quaker Bioventures, Safeguard, New Leaf Venture Partners, Domain Associates, 5Am Ventures, and Cardinal Partners.

About Wharton Health Care Business Conference:
Now in its 14th year, the conference has grown to become a leading health care forum for industry professionals, policy makers academics, and students. The annual two-day event typically draws over 600 attendees from across the nation. Attendees represent a broad range of functions including Business Development, Marketing, Corporate Strategy, Finance, and Clinical. To register and learn more about the conference, visit www.whcbc.org.

Media Contact:
Lynn Wang
WHCBC Co-Chair
info (at) whcbc (dot) org

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1Qcm9mLUNvdXAtTWFnbi1DcmFzLVNpbmctWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Lynn Wang
Wharton Health Care Business Conference
215-898-6861
Email us Here
ATTACHED FILES

Press Release Attachment

Press Release Attachment

Press Release Attachment

Press Release Attachment

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move